Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Abstract The prognosis of recurrent malignant peripheral nerve sheath tumors (MPNST) is dismal, with surgical resection being the only definitive salvage therapy. Treatment with chemoradiation approaches has not significantly improved patient outcomes. Similarly, trials of therapies targeting MPNST...
Guardado en:
Autores principales: | Sumanth Nagabushan, Loretta M. S. Lau, Paulette Barahona, Marie Wong, Alexandra Sherstyuk, Glenn M. Marshall, Vanessa Tyrrell, Eva A. Wegner, Paul G. Ekert, Mark J. Cowley, Chelsea Mayoh, Toby N. Trahair, Philip Crowe, Antoinette Anazodo, David S. Ziegler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1017be47b03249d190e20ce279c78746 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Case Report of Malignant Peripheral Nerve Sheath Tumor of the Breast
por: Kh Abdal, et al.
Publicado: (2019) -
Optic nerve sheath meningocele
por: Juan Carlos Mesa-Gutiérrez, et al.
Publicado: (2008) -
Amino group in Leptothrix sheath skeleton is responsible for direct deposition of Fe(III) minerals onto the sheaths
por: Tatsuki Kunoh, et al.
Publicado: (2017) -
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
por: Rita Alaggio, et al.
Publicado: (2013) -
Comparison of vacuum-assisted sheaths and normal sheaths in minimally invasive percutaneous nephrolithotomy: a systematic review and meta-analysis
por: Ling Zhu, et al.
Publicado: (2021)